Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects
The model integrates structured EHR data spanning patient characteristics, cancer treatment, vitals, lab results, medications and prior acute care utilization to determine an individual’s risk of requiring urgent care throughout the course of their treatment.
Hundreds of radiation therapy systems subject to FDA recall
A Class 2 recall has been issued for the systems due to a software glitch that could impact treatment accuracy.
FDA hits pause on novel radiation therapy's approval
The therapy previously earned the FDA’s Breakthrough Device Designation due to its potential to treat certain cancers.
3 industry partnerships, 1 clinical aim: Enriching the global supply chain of medical isotopes
Nuclear medicine operations may soon enjoy steadier flows of certain in-demand radioisotopes. If so, much credit will go to companies that had the strategic sense to collaborate with each other.
Tariffs will have a significant impact on the nuclear imaging supply chain in the US
"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

ASTRO, industry leaders issue new radiation treatment guidelines for early-stage prostate cancer

Prominent medical societies have issued new clinical guidelines, Thursday, Oct. 11, recommending physicians use external beam radiation therapy (EBRT) to treat men with early-stage prostate cancer.

Radiation Oncology

Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects

Hundreds of radiation therapy systems subject to FDA recall

FDA hits pause on novel radiation therapy's approval

3 industry partnerships, 1 clinical aim: Enriching the global supply chain of medical isotopes

Tariffs will have a significant impact on the nuclear imaging supply chain in the US